JPMorgan Chase & Co. Has $2.80 Million Stock Holdings in Transcat, Inc. (NASDAQ:TRNS)

JPMorgan Chase & Co. lifted its position in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 153.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 26,434 shares of the scientific and technical instruments company's stock after buying an additional 15,991 shares during the period. JPMorgan Chase & Co. owned approximately 0.28% of Transcat worth $2,795,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Geode Capital Management LLC raised its position in shares of Transcat by 5.4% during the third quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company's stock worth $26,269,000 after purchasing an additional 11,106 shares during the period. Annex Advisory Services LLC raised its position in shares of Transcat by 47.6% during the fourth quarter. Annex Advisory Services LLC now owns 24,461 shares of the scientific and technical instruments company's stock worth $2,587,000 after purchasing an additional 7,893 shares during the period. Rhumbline Advisers raised its position in shares of Transcat by 4.1% during the fourth quarter. Rhumbline Advisers now owns 12,348 shares of the scientific and technical instruments company's stock worth $1,306,000 after purchasing an additional 486 shares during the period. Barclays PLC raised its position in shares of Transcat by 393.0% during the third quarter. Barclays PLC now owns 15,130 shares of the scientific and technical instruments company's stock worth $1,826,000 after purchasing an additional 12,061 shares during the period. Finally, Principal Financial Group Inc. raised its position in shares of Transcat by 8.5% during the fourth quarter. Principal Financial Group Inc. now owns 5,002 shares of the scientific and technical instruments company's stock worth $529,000 after purchasing an additional 391 shares during the period. Institutional investors own 98.34% of the company's stock.

Insider Buying and Selling

In other news, Director Craig D. Cairns acquired 1,200 shares of the company's stock in a transaction that occurred on Friday, January 31st. The shares were purchased at an average price of $77.02 per share, for a total transaction of $92,424.00. Following the completion of the acquisition, the director now owns 1,910 shares of the company's stock, valued at approximately $147,108.20. This represents a 169.01 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 2.30% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

TRNS has been the topic of a number of recent analyst reports. StockNews.com lowered Transcat from a "hold" rating to a "sell" rating in a research report on Wednesday, February 5th. Oppenheimer lowered Transcat from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 29th. HC Wainwright dropped their price target on Transcat from $126.00 to $106.00 and set a "buy" rating on the stock in a research report on Wednesday, January 29th. Finally, Northland Securities reissued a "market perform" rating and set a $85.00 price target (down from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, Transcat presently has a consensus rating of "Hold" and an average target price of $111.50.

Transcat Stock Down 4.9 %

Shares of TRNS traded down $4.15 during midday trading on Monday, reaching $80.98. 98,370 shares of the stock were exchanged, compared to its average volume of 74,296. The company has a market cap of $753.84 million, a price-to-earnings ratio of 43.77 and a beta of 0.67. The company has a quick ratio of 1.98, a current ratio of 2.42 and a debt-to-equity ratio of 0.14. Transcat, Inc. has a 12-month low of $67.56 and a 12-month high of $147.12. The firm has a 50 day simple moving average of $77.08 and a 200-day simple moving average of $93.89.

Transcat (NASDAQ:TRNS - Get Free Report) last released its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 EPS for the quarter, topping analysts' consensus estimates of $0.38 by $0.07. Transcat had a return on equity of 7.23% and a net margin of 6.22%. During the same period in the prior year, the company earned $0.56 EPS. Research analysts forecast that Transcat, Inc. will post 2.3 EPS for the current year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.